July 19, 2021– Despite lifelong health challenges, Chicago resident Tracy Kimble exudes a spirit of perseverance and independence. But there was a time in his life when Tracy felt the despair of being forced to choose between supporting his family … [Read More...]
Boehringer Ingelheim Joins in the Attacks on 340B
Print ArticleJuly 12, 2021– The pharmaceutical giant Boehringer Ingelheim (BI), a manufacturer headquartered in Germany, is the latest company to announce it is cutting off discounts to safety-net hospitals participating in the 340B drug pricing program. If BI goes through with its threat on Aug. 1, it will become the seventh drug company to limit 340B […]
As Losses Mount, 340B Pharmacy Dispute Takes Twists and Turns
Print ArticleBy Maureen Testoni June 29, 2021– The year-long dispute over drug companies flouting the 340B statute and denying drug price discounts to hospitals, community health centers, and public health clinics partnering with community pharmacies continues to play out in Washington and in courts around the country. Since last summer, six drug companies – Eli […]
FOLLOW | SHARE | LIKE
